SCHEMBL14822787

SCHEMBL14822787

CCc1cc(C(C)(C)C)ccc1NC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.47
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NR1H4 Q96RI1 3/20 0.41
EPHX2 P34913 1/20 0.41
CYP2D6 P10635 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPK1 P28482 3/20 0.40
ALDH1A1 P00352 2/20 0.40
GLA P06280 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11619456 0.87 ESR1 (0.42) ESR1CYP1A2CYP2C9CYP2C19NPC1
SCHEMBL6693771 0.83 CYP1A2 (0.48) ESR1CYP1A2CYP2C9CYP2C19NPC1
SCHEMBL15604416 0.81 ESR1 (0.57) ESR1CYP1A2CYP2C9CYP2C19NPC1
SCHEMBL10627654 0.80 CYP2D6 (0.41) ESR1CYP1A2CYP2C19NPC1RAB9A
SCHEMBL7223016 0.79 CYP2C9 (0.50) ESR1CYP1A2CYP2C9CYP2C19NPC1
SCHEMBL23408935 0.79 ALDH1A1 (0.40) ESR1CYP1A2CYP2C19NPC1RAB9A
SCHEMBL7871930 0.79 NPC1 (0.61) NPC1RAB9AMAPTPOLBHTT
SCHEMBL5524582 0.78 HDAC1 (0.55) CYP1A2CYP2C9CYP2C19NPC1RAB9A
SCHEMBL3878977 0.78 CA1 (0.54) CYP2C19NPC1RAB9AMAPTPOLB
SCHEMBL2353155 0.78 MAPT (0.56) ESR1CYP1A2CYP2C9CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410155-B2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIA inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-02 US disclosed